BiomX Inc.
PHGE
$4.98
-$0.06-1.19%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -104.20% | -329.35% | 29.28% | 78.30% | 32.26% |
| Total Depreciation and Amortization | 62.06% | 145.89% | 78.71% | 106.39% | 107.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 138.26% | 127.90% | -194.98% | -385.60% | -1,963.98% |
| Change in Net Operating Assets | 99.23% | 97.51% | 119.99% | -8.42% | -220.88% |
| Cash from Operations | 28.64% | 23.39% | 15.97% | -24.42% | -73.72% |
| Capital Expenditure | 93.33% | 50.00% | 56.25% | 25.00% | 40.00% |
| Sale of Property, Plant, and Equipment | 34.15% | 63.01% | 100.00% | 13,200.00% | 8,100.00% |
| Cash Acquisitions | -- | -100.00% | -100.00% | -100.00% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -84.90% | -85.07% | -84.24% | -83.49% | -63.35% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | -152.69% |
| Issuance of Common Stock | 53,128.00% | 48,124.00% | 47,908.00% | 98.69% | -99.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -100.00% | -100.00% | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.42% | -101.83% | -101.83% | -102.45% | 8,456.46% |
| Cash from Financing | -65.63% | -69.18% | -68.22% | -72.29% | 1,223.70% |
| Foreign Exchange rate Adjustments | 7,200.00% | 103.13% | 881.82% | 192.11% | -83.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -716.77% | -1,418.12% | -954.19% | -265.68% | 112.85% |